Epigenetics and gene regulation are key factors in the development and progression of cancer, influencing how genes are expressed without changing the genetic code. These regulatory mechanisms, such as DNA methylation, histone modifications, and non-coding RNA activity, can have a profound impact on cellular behavior. In cancer, epigenetic alterations often lead to the activation of genes that promote tumor growth or the silencing of genes that prevent cancer, such as tumor suppressors. Unlike genetic mutations, which are permanent, epigenetic modifications can be reversible, making them an appealing target for cancer therapies. Researchers are exploring ways to manipulate these epigenetic changes to restore normal gene function and inhibit cancer cell growth. By understanding the role of epigenetics in cancer, scientists are also identifying new potential biomarkers for early detection and better predicting how tumors will respond to specific treatments. This approach offers promise for developing more precise and less harmful treatments for cancer patients.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States